Healthcare IT Today August 11, 2025
Extends Waystar’s AI Leadership Into Clinical Intelligence Software, Unlocking Greater Value for Clients and Shareholders
Highly Recurring Subscription-Based Business Projected to be Accretive to Waystar’s Financial Profile
Expected to Expand Waystar’s Total Addressable Market by More Than 15%
Waystar, a provider of leading healthcare payment software, today announced a definitive agreement to acquire 100% of Iodine Software from shareholders led by Advent International, a leading global private equity investor, for a total enterprise value of $1.25 billion. The proposed transaction is expected to accelerate Waystar’s ability to transform healthcare payments through its leading cloud-based software platform, empowering more than one million providers with advanced AI capabilities to prevent denials, reduce manual work, and improve financial performance.
Building on Waystar’s track...







